Christian P. Valcke
About Christian P. Valcke
Chris Valcke is the Chief Product Development Officer, specializing in product lifecycle management in the medical device and diagnostic industry, with a focus on products that aid in various medical fields.
Chris Valcke Chief Product Development Officer
Chris Valcke serves as the Chief Product Development Officer, a position he has held since January 2022. He heads the worldwide research and development efforts focusing on the innovation and advancement of products in the medical device and diagnostic industry. His leadership role emphasizes the seamless integration and management of the product lifecycle, ensuring that new and novel products are designed, developed, and brought to market efficiently and effectively.
Chris Valcke Education and Expertise
Chris Valcke has an in-depth educational background in electrical engineering and system science. He earned a Ph.D. in electrical engineering and an MS in System Science from the University of California, Los Angeles. His academic foundation was first established with a bachelor's degree in electrical engineering from KU Leuven in Belgium. Valcke's expertise lies in product lifecycle management, particularly in the medical device and diagnostic industry, where he has successfully commercialized products from concept to launch.
Chris Valcke Professional Background
Before becoming the Chief Product Development Officer, Chris Valcke held significant leadership positions at Invetech and Roche/Ventana Medical Systems. His experience at these companies equipped him with the necessary skills to oversee the development and commercialization of medical technologies. Valcke's extensive background includes guiding product development teams and managing projects aimed at improving healthcare through advanced technological solutions.
Chris Valcke Achievements in Medical Device and Diagnostic Industry
Chris Valcke has a proven track record of successfully commercializing a range of novel products that have made significant contributions to various areas of healthcare. Under his leadership, products aimed at aiding in cancer diagnosis, genetics, blood donation screening, hospital-acquired infections, and emergency medicine have been brought from concept through to development and market launch. These achievements highlight his ability to effectively lead product development initiatives in the medical device and diagnostic industry.